WHO ICTRP trial
Efficacy and safety of Argatroban plus clopidogrel versus aspirin plus…
ChiCTR2400080890 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400080890 |
|---|---|
| Public title | Efficacy and safety of Argatroban plus clopidogrel versus aspirin plus clopidogrel in the treatment of acute cerebral infarction: a single-center, parallel-design, randomized, controlled study of superiority |
| Scientific title | Efficacy and safety of Argatroban combined with clopidogrel versus aspirin combined with clopidogrel in patients with acute cerebral infarction |
| Primary sponsor | Affiliated Hospital of Guangdong Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Ischemic stroke |
| Interventions | Argatroban:Clopidogrel 75 mg qd oral + Agatroban injection was pumped intravenously for 60 mg/d (day 1 and day 2) / 10mg bid (days 2-5); after 7 days, clopidogrel 75 mg qd was used to 90 days;Control:Clopidogrel 75mg qd +aspirin 100 mg qd… |
| Registration date | Feb 17, 2024 |
| Target size | Argatroban:200;Control:200 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: